English

Catalent Pharma Solutions, Inc.

EDGAR

Quarterly report (10-Q) · filed 2014-04-23

27 filing records in this dataset, filed from 2008-05-15 to 2014-04-23. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

453 million USD

2014 Q3 · USD

Exact inputs and evidence

Revenue: 453100000 USD Source

Operating margin

13.29%

2014 Q3 · %

Exact inputs and evidence

Operating Income: 60200000 USD Source
Revenue: 453100000 USD Source

Operating cash flow

52.9 million USD

2014 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 93300000 USD Source
Operating Cash Flow: 40400000 USD Source

Cash and cash equivalents: 55.7 million USD 2014-03-31 Source
Exact value

55700000 USD
Long-term debt including current maturities: 2.69 billion USD 2013-06-30 Source
Exact value

2691600000 USD
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-04-23.

Financial data available through: 2013-06-30.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2013-06-30
Operating income: 4 of 11 periods available· newest 2013-06-30
Net income: 6 of 11 periods available· newest 2013-06-30
Operating cash flow: 6 of 11 periods available· newest 2013-06-30
Capital expenditure: 6 of 11 periods available· newest 2013-06-30
Total assets: 6 of 11 periods available· newest 2013-06-30
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2013-06-30
Current liabilities: 6 of 11 periods available· newest 2013-06-30
Cash and cash equivalents: 6 of 11 periods available· newest 2013-06-30
Long-term debt including current maturities: 3 of 11 periods available· newest 2013-06-30
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+6.2%

Prior period

USD 1.69 billion

2011-07-01 – 2012-06-30
Current period

USD 1.8 billion

2012-07-01 – 2013-06-30

Exact inputs and evidence

1800300000 − 1694800000 = 105500000 USD

1694800000 USD · 2011-07-01 – 2012-06-30
Inspect prior input Prior source
1800300000 USD · 2012-07-01 – 2013-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Year-over-year change in Revenue: 105500000 USD Concept: fundies:Revenue Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1800300000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#2118411 Filing: 000141608313000014 Input fundies:Revenue: 1694800000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#2118093 Filing: 000141608313000014
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 6.3 million

Prior period

−USD 40.4 million

2011-07-01 – 2012-06-30
Current period

−USD 46.7 million

2012-07-01 – 2013-06-30

Exact inputs and evidence

-46700000 − -40400000 = -6300000 USD

-40400000 USD · 2011-07-01 – 2012-06-30
Inspect prior input Prior source
-46700000 USD · 2012-07-01 – 2013-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Year-over-year change in Net income: -6300000 USD Concept: fundies:NetIncome Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -46700000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1354343 Filing: 000141608313000014 Input fundies:NetIncome: -40400000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1354189 Filing: 000141608313000014
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+56.7%

Prior period

USD 87.9 million

2011-07-01 – 2012-06-30
Current period

USD 137.7 million

2012-07-01 – 2013-06-30

Exact inputs and evidence

137700000 − 87900000 = 49800000 USD

87900000 USD · 2011-07-01 – 2012-06-30
Inspect prior input Prior source
137700000 USD · 2012-07-01 – 2013-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Year-over-year change in Operating cash flow: 49800000 USD Concept: fundies:OperatingCashFlow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 137700000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346213 Filing: 000141608313000014 Input fundies:OperatingCashFlow: 87900000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346002 Filing: 000141608313000014
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+17.6%

Prior period

USD 104.2 million

2011-07-01 – 2012-06-30
Current period

USD 122.5 million

2012-07-01 – 2013-06-30

Exact inputs and evidence

122500000 − 104200000 = 18300000 USD

104200000 USD · 2011-07-01 – 2012-06-30
Inspect prior input Prior source
122500000 USD · 2012-07-01 – 2013-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Year-over-year change in Capital expenditure: 18300000 USD Concept: fundies:CapitalExpenditure Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 122500000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1418862 Filing: 000141608313000014 Input fundies:CapitalExpenditure: 104200000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1419074 Filing: 000141608313000014
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2012-07-01 – 2013-06-30

Revenue USD 1.8 billion 100% of revenue
Operating costs Derived USD 1.6 billion 89% of revenue
Operating income USD 204.4 million 11% of revenue
Tax, interest and other Derived USD 251.1 million 14% of revenue
Net income −USD 46.7 million −2.6% of revenue

Cash

Operating cash flow USD 137.7 million 7.6% of revenue
Capital expenditure USD 122.5 million 6.8% of revenue
Free cash flow Derived USD 15.2 million 0.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Operating loss: operating costs were 104% of revenue.
2011 Net loss: net income was −3.5% of revenue.
2012 Net loss: net income was −2.4% of revenue.
2013 Net loss: net income was −2.6% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2007-07-01 – 2008-06-30	1817700000	Unavailable	Unavailable	Unavailable	-539700000	900000 Derived	Source 2007-07-01 – 2008-06-30: 1817700000 USD Inspect Revenue Open source 2007-07-01 – 2008-06-30: -539700000 USD Inspect Net Income Open source 2007-07-01 – 2008-06-30: 85300000 USD Inspect Operating Cash Flow Open source 2007-07-01 – 2008-06-30: 84400000 USD Inspect Capital Expenditure Open source
2009 2008-07-01 – 2009-06-30	1561600000	Unavailable	Unavailable	Unavailable	-308100000	-7500000 Derived	Source 2008-07-01 – 2009-06-30: 1561600000 USD Inspect Revenue Open source 2008-07-01 – 2009-06-30: -308100000 USD Inspect Net Income Open source 2008-07-01 – 2009-06-30: 76200000 USD Inspect Operating Cash Flow Open source 2008-07-01 – 2009-06-30: 83700000 USD Inspect Capital Expenditure Open source
2010 2009-07-01 – 2010-06-30	1480400000	1542100000 Derived	-61700000	227900000 Derived	-289600000	163300000 Derived	Source 2009-07-01 – 2010-06-30: 1480400000 USD Inspect Revenue Open source 2009-07-01 – 2010-06-30: -61700000 USD Inspect Operating Income Open source 2009-07-01 – 2010-06-30: -289600000 USD Inspect Net Income Open source 2009-07-01 – 2010-06-30: 233800000 USD Inspect Operating Cash Flow Open source 2009-07-01 – 2010-06-30: 70500000 USD Inspect Capital Expenditure Open source
2011 2010-07-01 – 2011-06-30	1531800000	1345700000 Derived	186100000	240100000 Derived	-54000000	12400000 Derived	Source 2010-07-01 – 2011-06-30: 1531800000 USD Inspect Revenue Open source 2010-07-01 – 2011-06-30: 186100000 USD Inspect Operating Income Open source 2010-07-01 – 2011-06-30: -54000000 USD Inspect Net Income Open source 2010-07-01 – 2011-06-30: 99700000 USD Inspect Operating Cash Flow Open source 2010-07-01 – 2011-06-30: 87300000 USD Inspect Capital Expenditure Open source
2012 2011-07-01 – 2012-06-30	1694800000	1496800000 Derived	198000000	238400000 Derived	-40400000	-16300000 Derived	Source 2011-07-01 – 2012-06-30: 1694800000 USD Inspect Revenue Open source 2011-07-01 – 2012-06-30: 198000000 USD Inspect Operating Income Open source 2011-07-01 – 2012-06-30: -40400000 USD Inspect Net Income Open source 2011-07-01 – 2012-06-30: 87900000 USD Inspect Operating Cash Flow Open source 2011-07-01 – 2012-06-30: 104200000 USD Inspect Capital Expenditure Open source
2013 2012-07-01 – 2013-06-30	1800300000	1595900000 Derived	204400000	251100000 Derived	-46700000	15200000 Derived	Source 2012-07-01 – 2013-06-30: 1800300000 USD Inspect Revenue Open source 2012-07-01 – 2013-06-30: 204400000 USD Inspect Operating Income Open source 2012-07-01 – 2013-06-30: -46700000 USD Inspect Net Income Open source 2012-07-01 – 2013-06-30: 137700000 USD Inspect Operating Cash Flow Open source 2012-07-01 – 2013-06-30: 122500000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.8B 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-06-30	Revenue	1817700000	Revenue: 1817700000 Open source
20092009-06-30	Revenue	1561600000	Revenue: 1561600000 Open source
20102010-06-30	Revenue	1480400000	Revenue: 1480400000 Open source
20112011-06-30	Revenue	1531800000	Revenue: 1531800000 Open source
20122012-06-30	Revenue	1694800000	Revenue: 1694800000 Open source
20132013-06-30	Revenue	1800300000	Revenue: 1800300000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

6.2% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-06-30	Year over year	No prior comparable period	Revenue: 1817700000 Open source
20092009-06-30	Year over year	-14.1%	Revenue: 1561600000 Open source Revenue: 1817700000 Open source
20102010-06-30	Year over year	-5.2%	Revenue: 1480400000 Open source Revenue: 1561600000 Open source
20112011-06-30	Year over year	3.5%	Revenue: 1531800000 Open source Revenue: 1480400000 Open source
20122012-06-30	Year over year	10.6%	Revenue: 1694800000 Open source Revenue: 1531800000 Open source
20132013-06-30	Year over year	6.2%	Revenue: 1800300000 Open source Revenue: 1694800000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 11.4% 2013

Net margin -2.6% 2013

Free cash flow margin 0.8% 2013

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2008-06-30	Operating margin	Not reported	Revenue: 1817700000 Open source
2009-06-30	Operating margin	Not reported	Revenue: 1561600000 Open source
20102010-06-30	Operating margin	-4.2%	Operating Income: -61700000 Open source Revenue: 1480400000 Open source
20112011-06-30	Operating margin	12.1%	Operating Income: 186100000 Open source Revenue: 1531800000 Open source
20122012-06-30	Operating margin	11.7%	Operating Income: 198000000 Open source Revenue: 1694800000 Open source
20132013-06-30	Operating margin	11.4%	Operating Income: 204400000 Open source Revenue: 1800300000 Open source
20082008-06-30	Net margin	-29.7%	Net Income: -539700000 Open source Revenue: 1817700000 Open source
20092009-06-30	Net margin	-19.7%	Net Income: -308100000 Open source Revenue: 1561600000 Open source
20102010-06-30	Net margin	-19.6%	Net Income: -289600000 Open source Revenue: 1480400000 Open source
20112011-06-30	Net margin	-3.5%	Net Income: -54000000 Open source Revenue: 1531800000 Open source
20122012-06-30	Net margin	-2.4%	Net Income: -40400000 Open source Revenue: 1694800000 Open source
20132013-06-30	Net margin	-2.6%	Net Income: -46700000 Open source Revenue: 1800300000 Open source
20082008-06-30	Free cash flow margin	0%	Revenue: 1817700000 Open source Operating Cash Flow: 85300000 Open source Capital Expenditure: 84400000 Open source
20092009-06-30	Free cash flow margin	-0.5%	Revenue: 1561600000 Open source Operating Cash Flow: 76200000 Open source Capital Expenditure: 83700000 Open source
20102010-06-30	Free cash flow margin	11%	Revenue: 1480400000 Open source Operating Cash Flow: 233800000 Open source Capital Expenditure: 70500000 Open source
20112011-06-30	Free cash flow margin	0.8%	Revenue: 1531800000 Open source Operating Cash Flow: 99700000 Open source Capital Expenditure: 87300000 Open source
20122012-06-30	Free cash flow margin	-1%	Revenue: 1694800000 Open source Operating Cash Flow: 87900000 Open source Capital Expenditure: 104200000 Open source
20132013-06-30	Free cash flow margin	0.8%	Revenue: 1800300000 Open source Operating Cash Flow: 137700000 Open source Capital Expenditure: 122500000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 137.7M 2013

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-06-30	Operating cash flow	85300000	Operating Cash Flow: 85300000 Open source
20092009-06-30	Operating cash flow	76200000	Operating Cash Flow: 76200000 Open source
20102010-06-30	Operating cash flow	233800000	Operating Cash Flow: 233800000 Open source
20112011-06-30	Operating cash flow	99700000	Operating Cash Flow: 99700000 Open source
20122012-06-30	Operating cash flow	87900000	Operating Cash Flow: 87900000 Open source
20132013-06-30	Operating cash flow	137700000	Operating Cash Flow: 137700000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 15.2M 2013

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-06-30	Free cash flow	900000	Operating Cash Flow: 85300000 Open source Capital Expenditure: 84400000 Open source
20092009-06-30	Free cash flow	-7500000	Operating Cash Flow: 76200000 Open source Capital Expenditure: 83700000 Open source
20102010-06-30	Free cash flow	163300000	Operating Cash Flow: 233800000 Open source Capital Expenditure: 70500000 Open source
20112011-06-30	Free cash flow	12400000	Operating Cash Flow: 99700000 Open source Capital Expenditure: 87300000 Open source
20122012-06-30	Free cash flow	-16300000	Operating Cash Flow: 87900000 Open source Capital Expenditure: 104200000 Open source
20132013-06-30	Free cash flow	15200000	Operating Cash Flow: 137700000 Open source Capital Expenditure: 122500000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-06-30	Liabilities / assets	Not reported	Total Assets: 3704300000 Open source
2009-06-30	Liabilities / assets	Not reported	Total Assets: 3131800000 Open source
2010-06-30	Liabilities / assets	Not reported	Total Assets: 2727400000 Open source
2011-06-30	Liabilities / assets	Not reported	Total Assets: 2831200000 Open source
2012-06-30	Liabilities / assets	Not reported	Total Assets: 3139000000 Open source
2013-06-30	Liabilities / assets	Not reported	Total Assets: 3056800000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.65× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-06-30	Current assets / current liabilities	2.03×	Current Assets: 701600000 Open source Current Liabilities: 345600000 Open source
20092009-06-30	Current assets / current liabilities	1.57×	Current Assets: 606000000 Open source Current Liabilities: 386500000 Open source
20102010-06-30	Current assets / current liabilities	1.79×	Current Assets: 682500000 Open source Current Liabilities: 382000000 Open source
20112011-06-30	Current assets / current liabilities	1.97×	Current Assets: 757700000 Open source Current Liabilities: 385500000 Open source
20122012-06-30	Current assets / current liabilities	1.6×	Current Assets: 704700000 Open source Current Liabilities: 439300000 Open source
20132013-06-30	Current assets / current liabilities	1.65×	Current Assets: 677900000 Open source Current Liabilities: 410300000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2007-07-01 – 2008-06-30	−USD 539.7 million Exact value Exact value: -539700000 USD 2007-07-01 – 2008-06-30: -539700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Catalent Pharma Solutions, Inc. · 2008-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Net Income: -539700000 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ANetIncome&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:NetIncome: -539700000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-10-212161.txt#7579 The citation records this snapshot. The page link may show a newer release later.	USD 85.3 million Exact value Exact value: 85300000 USD 2007-07-01 – 2008-06-30: 85300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Catalent Pharma Solutions, Inc. · 2008-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Operating Cash Flow: 85300000 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3AOperatingCashFlow&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 85300000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-10-212161.txt#9445 The citation records this snapshot. The page link may show a newer release later.	USD 84.4 million Exact value Exact value: 84400000 USD 2007-07-01 – 2008-06-30: 84400000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Catalent Pharma Solutions, Inc. · 2008-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Capital Expenditure: 84400000 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ACapitalExpenditure&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84400000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-10-212161.txt#9501 The citation records this snapshot. The page link may show a newer release later.	USD 900,000 Calculation and evidence 85300000 − 84400000 USD Exact free cash flow: 900000 USD 2007-07-01 – 2008-06-30: 85300000 USD · Inspect Operating Cash Flow · Source 2007-07-01 – 2008-06-30: 84400000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Catalent Pharma Solutions, Inc. · 2008-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Free cash flow: 900000 USD Concept: free-cash-flow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 85300000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-10-212161.txt#9445 Input fundies:CapitalExpenditure: 84400000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-10-212161.txt#9501 The citation records this snapshot. The page link may show a newer release later.
2009 2008-07-01 – 2009-06-30	−USD 308.1 million Exact value Exact value: -308100000 USD 2008-07-01 – 2009-06-30: -308100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Catalent Pharma Solutions, Inc. · 2009-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Net Income: -308100000 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: -308100000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-11-250474.txt#7903 The citation records this snapshot. The page link may show a newer release later.	USD 76.2 million Exact value Exact value: 76200000 USD 2008-07-01 – 2009-06-30: 76200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Catalent Pharma Solutions, Inc. · 2009-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Operating Cash Flow: 76200000 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 76200000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-11-250474.txt#9877 The citation records this snapshot. The page link may show a newer release later.	USD 83.7 million Exact value Exact value: 83700000 USD 2008-07-01 – 2009-06-30: 83700000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Catalent Pharma Solutions, Inc. · 2009-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Capital Expenditure: 83700000 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ACapitalExpenditure&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 83700000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-10-212161.txt#9501 The citation records this snapshot. The page link may show a newer release later.	−USD 7.5 million Calculation and evidence 76200000 − 83700000 USD Exact free cash flow: -7500000 USD 2008-07-01 – 2009-06-30: 76200000 USD · Inspect Operating Cash Flow · Source 2008-07-01 – 2009-06-30: 83700000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Catalent Pharma Solutions, Inc. · 2009-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Free cash flow: -7500000 USD Concept: free-cash-flow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 76200000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-11-250474.txt#9877 Input fundies:CapitalExpenditure: 83700000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/0001193125-10-212161.txt#9501 The citation records this snapshot. The page link may show a newer release later.
2010 2009-07-01 – 2010-06-30	−USD 289.6 million Exact value Exact value: -289600000 USD 2009-07-01 – 2010-06-30: -289600000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Catalent Pharma Solutions, Inc. · 2010-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Net Income: -289600000 USD Concept: fundies:NetIncome Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ANetIncome&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:NetIncome: -289600000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000119312512378353/csp-20120630.xml#4077005 Filing: 000119312512378353 The citation records this snapshot. The page link may show a newer release later.	USD 233.8 million Exact value Exact value: 233800000 USD 2009-07-01 – 2010-06-30: 233800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Catalent Pharma Solutions, Inc. · 2010-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Operating Cash Flow: 233800000 USD Concept: fundies:OperatingCashFlow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3AOperatingCashFlow&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 233800000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000119312512378353/csp-20120630.xml#4071598 Filing: 000119312512378353 The citation records this snapshot. The page link may show a newer release later.	USD 70.5 million Exact value Exact value: 70500000 USD 2009-07-01 – 2010-06-30: 70500000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Catalent Pharma Solutions, Inc. · 2010-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Capital Expenditure: 70500000 USD Concept: fundies:CapitalExpenditure Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ACapitalExpenditure&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 70500000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000119312512378353/csp-20120630.xml#4109807 Filing: 000119312512378353 The citation records this snapshot. The page link may show a newer release later.	USD 163.3 million Calculation and evidence 233800000 − 70500000 USD Exact free cash flow: 163300000 USD 2009-07-01 – 2010-06-30: 233800000 USD · Inspect Operating Cash Flow · Source 2009-07-01 – 2010-06-30: 70500000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Catalent Pharma Solutions, Inc. · 2010-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Free cash flow: 163300000 USD Concept: free-cash-flow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 233800000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000119312512378353/csp-20120630.xml#4071598 Filing: 000119312512378353 Input fundies:CapitalExpenditure: 70500000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000119312512378353/csp-20120630.xml#4109807 Filing: 000119312512378353 The citation records this snapshot. The page link may show a newer release later.
2011 2010-07-01 – 2011-06-30	−USD 54 million Exact value Exact value: -54000000 USD 2010-07-01 – 2011-06-30: -54000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Catalent Pharma Solutions, Inc. · 2011-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Net Income: -54000000 USD Concept: fundies:NetIncome Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ANetIncome&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:NetIncome: -54000000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1354497 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 99.7 million Exact value Exact value: 99700000 USD 2010-07-01 – 2011-06-30: 99700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Catalent Pharma Solutions, Inc. · 2011-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Operating Cash Flow: 99700000 USD Concept: fundies:OperatingCashFlow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3AOperatingCashFlow&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 99700000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346425 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 87.3 million Exact value Exact value: 87300000 USD 2010-07-01 – 2011-06-30: 87300000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Catalent Pharma Solutions, Inc. · 2011-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Capital Expenditure: 87300000 USD Concept: fundies:CapitalExpenditure Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ACapitalExpenditure&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 87300000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1418651 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 12.4 million Calculation and evidence 99700000 − 87300000 USD Exact free cash flow: 12400000 USD 2010-07-01 – 2011-06-30: 99700000 USD · Inspect Operating Cash Flow · Source 2010-07-01 – 2011-06-30: 87300000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Catalent Pharma Solutions, Inc. · 2011-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Free cash flow: 12400000 USD Concept: free-cash-flow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 99700000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346425 Filing: 000141608313000014 Input fundies:CapitalExpenditure: 87300000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1418651 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.
2012 2011-07-01 – 2012-06-30	−USD 40.4 million Exact value Exact value: -40400000 USD 2011-07-01 – 2012-06-30: -40400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Catalent Pharma Solutions, Inc. · 2012-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Net Income: -40400000 USD Concept: fundies:NetIncome Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ANetIncome&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:NetIncome: -40400000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1354189 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 87.9 million Exact value Exact value: 87900000 USD 2011-07-01 – 2012-06-30: 87900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Catalent Pharma Solutions, Inc. · 2012-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Operating Cash Flow: 87900000 USD Concept: fundies:OperatingCashFlow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3AOperatingCashFlow&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 87900000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346002 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 104.2 million Exact value Exact value: 104200000 USD 2011-07-01 – 2012-06-30: 104200000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Catalent Pharma Solutions, Inc. · 2012-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Capital Expenditure: 104200000 USD Concept: fundies:CapitalExpenditure Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ACapitalExpenditure&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 104200000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1419074 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	−USD 16.3 million Calculation and evidence 87900000 − 104200000 USD Exact free cash flow: -16300000 USD 2011-07-01 – 2012-06-30: 87900000 USD · Inspect Operating Cash Flow · Source 2011-07-01 – 2012-06-30: 104200000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Catalent Pharma Solutions, Inc. · 2012-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Free cash flow: -16300000 USD Concept: free-cash-flow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 87900000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346002 Filing: 000141608313000014 Input fundies:CapitalExpenditure: 104200000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1419074 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.
2013 2012-07-01 – 2013-06-30	−USD 46.7 million Exact value Exact value: -46700000 USD 2012-07-01 – 2013-06-30: -46700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Net Income: -46700000 USD Concept: fundies:NetIncome Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ANetIncome&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:NetIncome: -46700000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1354343 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 137.7 million Exact value Exact value: 137700000 USD 2012-07-01 – 2013-06-30: 137700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Operating Cash Flow: 137700000 USD Concept: fundies:OperatingCashFlow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3AOperatingCashFlow&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 137700000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346213 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 122.5 million Exact value Exact value: 122500000 USD 2012-07-01 – 2013-06-30: 122500000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Capital Expenditure: 122500000 USD Concept: fundies:CapitalExpenditure Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083/explain?concept=fundies%3ACapitalExpenditure&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 122500000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1418862 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.	USD 15.2 million Calculation and evidence 137700000 − 122500000 USD Exact free cash flow: 15200000 USD 2012-07-01 – 2013-06-30: 137700000 USD · Inspect Operating Cash Flow · Source 2012-07-01 – 2013-06-30: 122500000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Catalent Pharma Solutions, Inc. · 2013-06-30 Catalent Pharma Solutions, Inc. (edgar:1416083) Free cash flow: 15200000 USD Concept: free-cash-flow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T20:23:04Z Snapshot: 01bef02d9ab5898374ce2a3d18046d3bc7ec317d4268e044f2718421038e7cee Dimensions: Consolidated View: https://fundies.io/companies/edgar/1416083?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 137700000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1346213 Filing: 000141608313000014 Input fundies:CapitalExpenditure: 122500000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1416083/000141608313000014/ck0001416083-20130630.xml#1418862 Filing: 000141608313000014 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

27 filings · 1,448 latest values · 1,448 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001416083, 1416083, edgar:1416083

Also known as CATALENT PHARMA SOLUTIONS, INC., Catalent Pharma Solutions, Inc.

Catalent Pharma Solutions, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2013 2012-07-01 – 2013-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation